Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dose of Misoprostol Combined with Oxytocin for Preventing Postpartum Hemorrhage in Cesarean Section
TCTR20211102001Phase 2Completed
- Sponsor
- Phayao Hospital
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of misoprostol, oxytocin in postpartum hemorrhage (PPH), sponsored by Phayao Hospital. Started May 2017; status: completed.
02
Drugs
misoprostoloxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on TCTR20211102001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211102001.